Chih-Yeu Fang

Chih-Yeu Fang

Auto-generated profile, based on publicly available information

Chih-Yeu Fang

National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan town, Miaoli County, Taiwan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CFChih-Yeu Fang
Chih-Yeu Fang
CWChung-Chun Wu
Chung-Chun Wu
CFChia-Lang Fang
Chia-Lang Fang
WCWei-Yu Chen
Wei-Yu Chen
Chi-Long ChenChi-Long Chen
Chi-Long Chen
Fetal bovine serum (FBS) is depended upon by investigators as an indispensable supplement in cell and tissue culture systems. Due to increased demand and limited availability, the price of FBS has increased by greater than 300% in the past few years. In addition, there are ethical and scientific controversies about the collection and use of FBS in culture systems. In response to the shortage of FBS, many FBS alternative serum products have been developed. Although many have claimed comparable performance to FBS, their support of long-term cell growth and effects on cell phenotype have not been revealed. In this study, we examined the performances of six bovine calf serum-based FBS alternatives in six head and neck cell lines and compared them with FBS. The results indicate that some of these sera had growth promoting capabilities comparable or superior to that of FBS. Additionally, these alternative sera supported long-term (30 passages) growth of tested cells and exhibited plating efficiencies comparable to that of FBS. Cells cultured in alternative sera also exhibited comparable anchorage-independent growth and similar drug inhibition responses in FBS. Still, caution should be taken in choosing suitable sera given that changes in cell morphology and variations in chemotactic responses were noted for cells maintained in certain sera. These FBS alternatives are more readily available, cost less, and are associated with less ethical concerns, thus making them attractive alternatives to FBS in cell culture systems.

19 August 2021 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
CFChih-Yeu Fang
Chih-Yeu Fang
CLChia-Chyi Liu
Chia-Chyi Liu
Hand, foot, and mouth disease (HFMD) poses a great threat to young children in the Asia-Pacific region. HFMD is usually caused by enterovirus A, and infection with enterovirus A71 (EV-A71) is parti...

4 June 2019 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
CFChih‐Yeu Fang
Chih‐Yeu Fang
YLYun‐Ho Lin
Yun‐Ho Lin
Chi-Long ChenChi-Long Chen
Chi-Long Chen

13 February 2023 in The Journal of Pathology: Clinical Research
Verified
Journal Article
Open access
CLChien-Hsiu Li
Chien-Hsiu Li
CFChih‐Yeu Fang
Chih‐Yeu Fang
MCMing-Hsien Chan
Ming-Hsien Chan
PLPei-Jung Lu
Pei-Jung Lu
LGLuo‐Ping Ger
Luo‐Ping Ger
Michael HsiaoMichael Hsiao
Michael Hsiao
Cancer progression is influenced by junctional adhesion molecule (JAM) family members. The relationship between JAM family members and different types of cancer was examined using The Cancer Genome Atlas dataset. mRNA levels of the F11R (F11 receptor) in tumours were inversely correlated to the expression of JAM‐2 and JAM‐3. This relationship was unique to breast cancer (BCa) and was associated with poor prognosis (p = 0.024, hazard ratio = 1.44 [1.05–1.99]). A 50‐gene molecular signature (prediction analysis of microarray 50) was used to subtype BCa. F11R mRNA expression significantly increased in human epidermal growth factor receptor 2 (HER2)‐enriched (p = 0.0035) and basal‐like BCa tumours (p = 0.0005). We evaluated F11R protein levels in two different compositions of BCa subtype patient tissue array cohorts to determine the relationship between BCa subtype and prognosis. Immunohistochemistry staining revealed that a high F11R protein level was associated with poor overall survival (p < 0.001; Taipei Medical University [TMU] cohort, p < 0.001; Kaohsiung Veterans General Hospital [KVGH] cohort) or disease‐free survival (p < 0.001 [TMU cohort], p = 0.034 [KVGH cohort]) in patients with BCa. Comparison of F11R levels in different subtypes revealed the association of poor prognosis with high levels of F11R among luminal (p < 0.001 [TMU cohort], p = 0.027 [KVGH cohort]), HER2 positive (p = 0.018 [TMU cohort], p = 0.037 [KVGH cohort]), and triple‐negative (p = 0.013 [TMU cohort], p = 0.037 [KVGH cohort]) BCa. F11R‐based RNA microarray analysis and Ingenuity Pathway Analysis were successful in profiling the detailed gene ontology of triple‐negative BCa cells regulated by F11R. The EP300 transcription factor was highly correlated with F11R in BCa (R = 0.51, p < 0.001). By analysing these F11R‐affected molecules with the L1000CDs datasets, we were able to predict some repurposing drugs for potential application in F11R‐positive BCa treatment.

6 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Kuen-Haur LeeKuen-Haur Lee
Kuen-Haur Lee
Chi-Long ChenChi-Long Chen
Chi-Long Chen
YLYi-Chao Lee
Yi-Chao Lee
TKTzu-Jen Kao
Tzu-Jen Kao
KCKai-Yun Chen
Kai-Yun Chen
CHChi-Chen Huang
Chi-Chen Huang
Malignant glioblastoma multiforme (GBM) is an aggressive brain tumor with strong local invasive growth and a poor prognosis. One probable way to manipulate GBM cells toward a less invasive status is to reprogram the most malignant GBM cells to a more differentiated and less oncogenic phenotype. Herein, we identified a novel role of a RING finger protein Znf179 in gliomagenesis. Znf179 overexpression induced differentiation of primary GBM cells, which were accompanied with elevated glial fibrillary acidic protein (GFAP) expression through up-regulating several cell-cycle-related factors, p53, p21, and p27, and allowed the cell-cycle arrest in the G0/G1 phase. In addition, Znf179 was highly correlated with the prognosis and survival rates of glioma patients. The expression levels of Znf179 was relatively lower in glioma patients compared to normal people, and glioma patients with lower expression levels of Znf179 mRNA had poorer prognosis and lower survival rates. In conclusion, we provide novel insight that Znf179 can reprogram GBM cells into a more-differentiated phenotype and prevent the progression of gliomas to a more-malignant state through p53-mediated cell-cycle signaling pathways. Understanding the molecular mechanism of Znf179 in gliomagenesis could help predict prognostic consequences, and targeting Znf179 could be a potential biomarker for glioma progression.

24 March 2023 in Virus Research
Verified
Journal Article
Open access
SLSheng-Chieh Lien
Sheng-Chieh Lien
YSYu-Sheng Shen
Yu-Sheng Shen
HLHsiao-Yu Lin
Hsiao-Yu Lin
SWShang-Rung Wu
Shang-Rung Wu
CFChih-Yeu Fang
Chih-Yeu Fang
CLChia-Chyi Liu
Chia-Chyi Liu
• Many coxsackievirus A10 isolates have low culture efficiency in vero cells. • HEK293A cell is a suitable cell line for coxsackievirus A10 propagation. • A serum-free HEK293A cell culture was developed for coxsackievirus A10 production. • Other enteroviruses could also be propagated in serum-free HEK293A cell culture.